| scholarly article | Q13442814 |
| P50 | author | John D Hainsworth | Q73567269 |
| Tiffanie M. Markus | Q90454243 | ||
| P2093 | author name string | Howard A Burris | |
| David R Spigel | |||
| F Anthony Greco | |||
| Dianna Shipley | |||
| Scott Lunin | |||
| Michel Kuzur | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
| Individual patient data meta-analyses in head and neck carcinoma: what have we learnt? | Q30986294 | ||
| Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck | Q33343271 | ||
| Carboplatin dosage: prospective evaluation of a simple formula based on renal function | Q33429552 | ||
| Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck | Q34287207 | ||
| Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study | Q34471062 | ||
| Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck | Q34533587 | ||
| Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer | Q40435669 | ||
| Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network | Q44106878 | ||
| Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience | Q44272428 | ||
| Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. | Q45152760 | ||
| Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer | Q46795073 | ||
| Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Base | Q57949385 | ||
| Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm | Q82676913 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 2138-2146 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck | |
| P478 | volume | 115 |
| Q54535177 | A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. |
| Q38806115 | Current Role of Dacomitinib in Head and Neck Cancer |
| Q34618994 | EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma |
| Q38240998 | Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer |
| Q35098322 | Emerging drugs to treat squamous cell carcinomas of the head and neck |
| Q38149327 | Emerging tyrosine kinase inhibitors for head and neck cancer |
| Q37791776 | Empowering induction therapy for locally advanced head and neck cancer |
| Q37977877 | Molecular targeting agents in the context of primary chemoradiation strategies |
| Q36303845 | New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN). |
| Q36713320 | Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma |
| Q59606033 | Radiotherapy plus EGFR inhibitors: synergistic modalities. |
| Q83015772 | Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck |
| Q36529843 | Systemic therapy strategies for head-neck carcinomas: Current status |
| Q37988981 | Targeted therapy in head and neck cancer |
| Q37766374 | Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab |
Search more.